Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a new revision tag, v3.6.3, replacing the previous v3.6.2. This appears to be a small maintenance update and does not alter the study information, eligibility criteria, or locations.SummaryDifference0.0%

- Check11 days agoChange Detected- The page revision tag was updated from v3.6.0 to v3.6.2, reflecting a minor metadata update to the study page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study record now states that recruitment has ended with 'No longer looking for participants.' This indicates the trial is terminated and no new participants are being enrolled.SummaryDifference0.3%

- Check33 days agoChange DetectedThe page now shows a new revision tag, 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. This indicates an updated version of the page for QC and record-keeping without changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small backend/template update. This change does not modify the substantive content or user-facing information on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a platform/site release rather than a change to the study record itself.SummaryDifference0.0%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.